Some Panomics Customers ‘Surprised,’ ‘Concerned’ About Affy’s Impending Buy

Affymetrix’s announcement last week that it plans to acquire Panomics for $73 million in cash did not go unnoticed by Panomics’ customers, several of whom this week said they were surprised by the move and expressed concern about how the deal may impact their ongoing research programs.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories